Kazia Therapeutics (KZIA) Enterprise Value (2009 - 2025)
Kazia Therapeutics (KZIA) reported Enterprise Value of -$45.6 million for Q4 2025, down 2175.82% on a YoY basis from $2.2 million in Q4 2024, and down 1539.03% quarter-over-quarter from -$2.8 million in Q2 2025.
Kazia Therapeutics (KZIA) Enterprise Value (2009 - 2025) Analysis & Trends
Kazia Therapeutics has reported Enterprise Value for 15 years, with the latest figure at -$45.6 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 2175.82% year-over-year to -$45.6 million; the trailing twelve-month figure through Dec 2025 stood at -$45.6 million (down 2175.82% YoY), and the FY2025 full-year result was -$2.8 million, down 154.81% from the prior year.
- Enterprise Value for Q4 2025 stood at -$45.6 million, down from -$2.8 million in the prior quarter.
- The five-year high for Enterprise Value was -$1.1 million in Q2 2024, with the low at -$45.6 million in Q4 2025.
- Historically, Enterprise Value has averaged -$9.8 million across 5 years, with a median of -$3.2 million in 2023.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 75.18% — and 2025, when it slumped 2175.82%.
- Kazia Therapeutics' Enterprise Value stood at -$11.1 million in 2021, then jumped by 73.93% to -$2.9 million in 2022, then climbed by 19.6% to -$2.3 million in 2023, then increased by 13.59% to -$2.0 million in 2024, then tumbled by 2175.82% to -$45.6 million in 2025.
- The last three Enterprise Value figures came in at -$45.6 million (Q4 2025), -$2.8 million (Q2 2025), and -$2.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Kazia Therapeutics | 1.70 Bn | 1.70 Bn | - | -45.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.61 Mn |
| Jun 30, 2025 | -2.78 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Jun 30, 2024 | -1.09 Mn |
| Dec 31, 2023 | -2.32 Mn |
| Jun 30, 2023 | -3.50 Mn |
| Dec 31, 2022 | -2.88 Mn |
| Jun 30, 2022 | -5.27 Mn |
| Dec 31, 2021 | -11.07 Mn |
| Jun 30, 2021 | -21.24 Mn |
| Dec 31, 2020 | -14.16 Mn |
| Jun 30, 2020 | -5.74 Mn |
| Dec 31, 2019 | -4.40 Mn |
| Jun 30, 2019 | -3.81 Mn |
| Dec 31, 2018 | -3.88 Mn |
| Jun 30, 2018 | -4.51 Mn |
| Jun 30, 2017 | -10.86 Mn |
| Dec 31, 2016 | -4.98 Mn |
| Jun 30, 2016 | -24.98 Mn |
| Aug 30, 2013 | -2.53 Mn |